HEADER TRANSCRIPTION/TRANSCRIPTION AGONIST 27-OCT-10 3PEQ
TITLE PPARD COMPLEXED WITH A PHENOXYACETIC ACID PARTIAL AGONIST
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA;
COMPND 3 CHAIN: A, B;
COMPND 4 FRAGMENT: UNP RESIDUES 171-441;
COMPND 5 SYNONYM: PPAR-DELTA, NUCI, NUCLEAR HORMONE RECEPTOR 1, NUC1, NUCLEAR
COMPND 6 RECEPTOR SUBFAMILY 1 GROUP C MEMBER 2, PEROXISOME PROLIFERATOR-
COMPND 7 ACTIVATED RECEPTOR BETA, PPAR-BETA;
COMPND 8 ENGINEERED: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS;
SOURCE 3 ORGANISM_COMMON: HUMAN;
SOURCE 4 ORGANISM_TAXID: 9606;
SOURCE 5 GENE: NR1C2, PPARB, PPARD;
SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693;
SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21;
SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID;
SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PRSETA
KEYWDS PPAR NUCLEAR RECEPTOR, TRANSCRIPTION-TRANSCRIPTION AGONIST COMPLEX
EXPDTA X-RAY DIFFRACTION
AUTHOR M.H.LAMBERT,K.A.EVANS,B.G.SHEARER,D.D.WISNOSKI,D.SHI,J.JIN,
AUTHOR 2 R.A.RIVERO,S.M.SPARKS,D.A.WINEGAR,A.N.BILLIN,C.BRITT,J.M.WAY,
AUTHOR 3 L.M.LEESNITZER,R.V.MERRIHEW
REVDAT 4 06-SEP-23 3PEQ 1 HETSYN
REVDAT 3 29-JUL-20 3PEQ 1 REMARK SITE
REVDAT 2 08-OCT-14 3PEQ 1 AUTHOR
REVDAT 1 12-OCT-11 3PEQ 0
JRNL AUTH K.A.EVANS,B.G.SHEARER,D.D.WISNOSKI,D.SHI,S.M.SPARKS,
JRNL AUTH 2 D.D.STERNBACH,D.A.WINEGAR,A.N.BILLIN,C.BRITT,J.M.WAY,
JRNL AUTH 3 A.H.EPPERLY,L.M.LEESNITZER,R.V.MERRIHEW,R.X.XU,M.H.LAMBERT,
JRNL AUTH 4 J.JIN
JRNL TITL PHENOXYACETIC ACID PPARD PARTIAL AGONISTS FOR THE TREATMENT
JRNL TITL 2 OF TYPE 2 DIABETES: SYNTHESIS, OPTIMIZATION, AND IN VIVO
JRNL TITL 3 EFFICACY
JRNL REF BIOORG.MED.CHEM.LETT. V. 21 2345 2011
JRNL REFN ISSN 0960-894X
JRNL PMID 21414782
JRNL DOI 10.1016/J.BMCL.2011.02.077
REMARK 2
REMARK 2 RESOLUTION. 2.40 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : REFMAC 5.5.0109
REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER,
REMARK 3 : NICHOLLS,WINN,LONG,VAGIN
REMARK 3
REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.26
REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000
REMARK 3 COMPLETENESS FOR RANGE (%) : 97.6
REMARK 3 NUMBER OF REFLECTIONS : 25794
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.201
REMARK 3 R VALUE (WORKING SET) : 0.199
REMARK 3 FREE R VALUE : 0.237
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100
REMARK 3 FREE R VALUE TEST SET COUNT : 1390
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 20
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46
REMARK 3 REFLECTION IN BIN (WORKING SET) : 1891
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 94.78
REMARK 3 BIN R VALUE (WORKING SET) : 0.2360
REMARK 3 BIN FREE R VALUE SET COUNT : 108
REMARK 3 BIN FREE R VALUE : 0.2860
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 4064
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 136
REMARK 3 SOLVENT ATOMS : 167
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : NULL
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 48.36
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : 0.69000
REMARK 3 B22 (A**2) : 2.36000
REMARK 3 B33 (A**2) : -2.89000
REMARK 3 B12 (A**2) : 0.00000
REMARK 3 B13 (A**2) : 0.58000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED OVERALL COORDINATE ERROR.
REMARK 3 ESU BASED ON R VALUE (A): NULL
REMARK 3 ESU BASED ON FREE R VALUE (A): 0.241
REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.170
REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.300
REMARK 3
REMARK 3 CORRELATION COEFFICIENTS.
REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.948
REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT
REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4320 ; 0.007 ; 0.022
REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 5860 ; 1.053 ; 1.995
REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL
REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 517 ; 4.704 ; 5.000
REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 186 ;36.270 ;24.140
REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 730 ;13.435 ;15.000
REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;17.237 ;15.000
REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 675 ; 0.067 ; 0.200
REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3279 ; 0.004 ; 0.021
REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL
REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2587 ; 0.364 ; 1.500
REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4174 ; 0.715 ; 2.000
REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1733 ; 1.042 ; 3.000
REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1681 ; 1.778 ; 4.500
REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT
REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL
REMARK 3
REMARK 3 NCS RESTRAINTS STATISTICS
REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL
REMARK 3
REMARK 3 TLS DETAILS
REMARK 3 NUMBER OF TLS GROUPS : 2
REMARK 3
REMARK 3 TLS GROUP : 1
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : A 209 A 475
REMARK 3 ORIGIN FOR THE GROUP (A): 28.1660 8.1280 66.1630
REMARK 3 T TENSOR
REMARK 3 T11: 0.0484 T22: 0.0241
REMARK 3 T33: 0.0511 T12: 0.0001
REMARK 3 T13: -0.0185 T23: -0.0009
REMARK 3 L TENSOR
REMARK 3 L11: 2.7204 L22: 2.2629
REMARK 3 L33: 3.3815 L12: 0.3096
REMARK 3 L13: -0.7925 L23: 0.3364
REMARK 3 S TENSOR
REMARK 3 S11: -0.0388 S12: 0.1493 S13: -0.1580
REMARK 3 S21: 0.0759 S22: 0.0497 S23: 0.0651
REMARK 3 S31: -0.0203 S32: -0.2326 S33: -0.0110
REMARK 3
REMARK 3 TLS GROUP : 2
REMARK 3 NUMBER OF COMPONENTS GROUP : 1
REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI
REMARK 3 RESIDUE RANGE : B 209 B 477
REMARK 3 ORIGIN FOR THE GROUP (A): 0.0480 -1.6290 18.9240
REMARK 3 T TENSOR
REMARK 3 T11: 0.1892 T22: 0.0342
REMARK 3 T33: 0.0451 T12: -0.0372
REMARK 3 T13: 0.0384 T23: -0.0139
REMARK 3 L TENSOR
REMARK 3 L11: 2.2286 L22: 2.0580
REMARK 3 L33: 7.0576 L12: 0.5513
REMARK 3 L13: 0.0826 L23: -1.1041
REMARK 3 S TENSOR
REMARK 3 S11: -0.0032 S12: 0.0847 S13: 0.1409
REMARK 3 S21: -0.0576 S22: 0.0938 S23: 0.0418
REMARK 3 S31: -0.4607 S32: 0.3365 S33: -0.0906
REMARK 3
REMARK 3 BULK SOLVENT MODELLING.
REMARK 3 METHOD USED : MASK
REMARK 3 PARAMETERS FOR MASK CALCULATION
REMARK 3 VDW PROBE RADIUS : 1.40
REMARK 3 ION PROBE RADIUS : 0.80
REMARK 3 SHRINKAGE RADIUS : 0.80
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING
REMARK 3 POSITIONS
REMARK 4
REMARK 4 3PEQ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 01-NOV-10.
REMARK 100 THE DEPOSITION ID IS D_1000062287.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 12-JUN-06
REMARK 200 TEMPERATURE (KELVIN) : 100
REMARK 200 PH : 9.0
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : Y
REMARK 200 RADIATION SOURCE : APS
REMARK 200 BEAMLINE : 17-ID
REMARK 200 X-RAY GENERATOR MODEL : NULL
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.0
REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI
REMARK 200 OPTICS : NULL
REMARK 200
REMARK 200 DETECTOR TYPE : CCD
REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000
REMARK 200 DATA SCALING SOFTWARE : HKL-2000
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25794
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400
REMARK 200 RESOLUTION RANGE LOW (A) : 30.260
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0
REMARK 200 DATA REDUNDANCY : 3.000
REMARK 200 R MERGE (I) : 0.07500
REMARK 200 R SYM (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 17.0000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.46
REMARK 200 COMPLETENESS FOR SHELL (%) : 94.8
REMARK 200 DATA REDUNDANCY IN SHELL : 2.60
REMARK 200 R MERGE FOR SHELL (I) : 0.43000
REMARK 200 R SYM FOR SHELL (I) : NULL
REMARK 200 <I/SIGMA(I)> FOR SHELL : 2.000
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: AMORE
REMARK 200 STARTING MODEL: PDB ENTRY 1GWX
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 59.36
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.03
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM POTASSIUM IODIDE, 20% PEG3350,
REMARK 280 PH 9.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -X,Y+1/2,-Z
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 47.76750
REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1, 2, 3
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 2
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350
REMARK 350 BIOMOLECULE: 3
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 2780 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 22950 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -17.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 APPLY THE FOLLOWING TO CHAINS: B
REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 26.43720
REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 47.76750
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 95.65295
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 GLN A 207
REMARK 465 VAL A 208
REMARK 465 GLY A 239
REMARK 465 LYS A 240
REMARK 465 ALA A 241
REMARK 465 SER A 242
REMARK 465 HIS A 243
REMARK 465 THR A 244
REMARK 465 LYS A 265
REMARK 465 GLN A 266
REMARK 465 LEU A 267
REMARK 465 VAL A 268
REMARK 465 ASN A 269
REMARK 465 GLY A 270
REMARK 465 MET A 476
REMARK 465 TYR A 477
REMARK 465 GLN B 207
REMARK 465 VAL B 208
REMARK 465 GLY B 239
REMARK 465 LYS B 240
REMARK 465 ALA B 241
REMARK 465 SER B 242
REMARK 465 HIS B 243
REMARK 465 THR B 244
REMARK 465 LYS B 265
REMARK 465 GLN B 266
REMARK 465 LEU B 267
REMARK 465 VAL B 268
REMARK 465 ASN B 269
REMARK 465 GLY B 270
REMARK 470
REMARK 470 MISSING ATOM
REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER;
REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER;
REMARK 470 I=INSERTION CODE):
REMARK 470 M RES CSSEQI ATOMS
REMARK 470 LYS A 212 CG CD CE NZ
REMARK 470 LYS A 260 CD CE NZ
REMARK 470 LEU A 262 CG CD1 CD2
REMARK 470 LYS A 336 CE NZ
REMARK 470 GLN A 429 CG CD OE1 NE2
REMARK 470 TYR A 430 CD1 CD2 CE1 CE2 CZ OH
REMARK 470 GLU A 462 CG CD OE1 OE2
REMARK 470 ASP B 210 CG OD1 OD2
REMARK 470 LYS B 212 CG CD CE NZ
REMARK 470 LYS B 216 CG CD CE NZ
REMARK 470 LYS B 232 CG CD CE NZ
REMARK 470 THR B 238 OG1 CG2
REMARK 470 LYS B 260 CD CE NZ
REMARK 470 LEU B 262 CG CD1 CD2
REMARK 470 LYS B 336 CG CD CE NZ
REMARK 470 GLN B 429 CG CD OE1 NE2
REMARK 470 TYR B 430 CG CD1 CD2 CE1 CE2 CZ OH
REMARK 470 ARG B 455 CG CD NE CZ NH1 NH2
REMARK 470 LYS B 458 CG CD CE NZ
REMARK 470 GLU B 462 CG CD OE1 OE2
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 LYS A 260 20.13 -70.24
REMARK 500 TYR A 430 51.99 39.18
REMARK 500 GLU A 460 75.97 -100.60
REMARK 500 VAL B 263 -36.55 -130.79
REMARK 500 ASP B 427 35.63 -99.76
REMARK 500
REMARK 500 REMARK: NULL
DBREF 3PEQ A 207 477 UNP Q03181 PPARD_HUMAN 171 441
DBREF 3PEQ B 207 477 UNP Q03181 PPARD_HUMAN 171 441
SEQRES 1 A 271 GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE TYR
SEQRES 2 A 271 ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS LYS
SEQRES 3 A 271 ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR ALA
SEQRES 4 A 271 PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN ALA
SEQRES 5 A 271 GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU
SEQRES 6 A 271 PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR ARG
SEQRES 7 A 271 CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU THR
SEQRES 8 A 271 GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU PHE
SEQRES 9 A 271 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS
SEQRES 10 A 271 GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN LYS
SEQRES 11 A 271 ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL THR
SEQRES 12 A 271 ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER ASP
SEQRES 13 A 271 ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN
SEQRES 14 A 271 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE ILE
SEQRES 15 A 271 ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU MET
SEQRES 16 A 271 ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE LEU
SEQRES 17 A 271 ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP
SEQRES 18 A 271 ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET ALA
SEQRES 19 A 271 ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET MET
SEQRES 20 A 271 GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU HIS
SEQRES 21 A 271 PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR
SEQRES 1 B 271 GLN VAL ALA ASP LEU LYS ALA PHE SER LYS HIS ILE TYR
SEQRES 2 B 271 ASN ALA TYR LEU LYS ASN PHE ASN MET THR LYS LYS LYS
SEQRES 3 B 271 ALA ARG SER ILE LEU THR GLY LYS ALA SER HIS THR ALA
SEQRES 4 B 271 PRO PHE VAL ILE HIS ASP ILE GLU THR LEU TRP GLN ALA
SEQRES 5 B 271 GLU LYS GLY LEU VAL TRP LYS GLN LEU VAL ASN GLY LEU
SEQRES 6 B 271 PRO PRO TYR LYS GLU ILE SER VAL HIS VAL PHE TYR ARG
SEQRES 7 B 271 CYS GLN CYS THR THR VAL GLU THR VAL ARG GLU LEU THR
SEQRES 8 B 271 GLU PHE ALA LYS SER ILE PRO SER PHE SER SER LEU PHE
SEQRES 9 B 271 LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY VAL HIS
SEQRES 10 B 271 GLU ALA ILE PHE ALA MET LEU ALA SER ILE VAL ASN LYS
SEQRES 11 B 271 ASP GLY LEU LEU VAL ALA ASN GLY SER GLY PHE VAL THR
SEQRES 12 B 271 ARG GLU PHE LEU ARG SER LEU ARG LYS PRO PHE SER ASP
SEQRES 13 B 271 ILE ILE GLU PRO LYS PHE GLU PHE ALA VAL LYS PHE ASN
SEQRES 14 B 271 ALA LEU GLU LEU ASP ASP SER ASP LEU ALA LEU PHE ILE
SEQRES 15 B 271 ALA ALA ILE ILE LEU CYS GLY ASP ARG PRO GLY LEU MET
SEQRES 16 B 271 ASN VAL PRO ARG VAL GLU ALA ILE GLN ASP THR ILE LEU
SEQRES 17 B 271 ARG ALA LEU GLU PHE HIS LEU GLN ALA ASN HIS PRO ASP
SEQRES 18 B 271 ALA GLN TYR LEU PHE PRO LYS LEU LEU GLN LYS MET ALA
SEQRES 19 B 271 ASP LEU ARG GLN LEU VAL THR GLU HIS ALA GLN MET MET
SEQRES 20 B 271 GLN ARG ILE LYS LYS THR GLU THR GLU THR SER LEU HIS
SEQRES 21 B 271 PRO LEU LEU GLN GLU ILE TYR LYS ASP MET TYR
HET 3EQ A 1 38
HET JZR A 478 18
HET JZR A 3 18
HET IOD A 2 1
HET IOD A 6 1
HET IOD A 7 1
HET IOD A 8 1
HET 3EQ B 2 38
HET JZR B 478 18
HET IOD B 3 1
HET IOD B 5 1
HETNAM 3EQ [(4-{BUTYL[2-METHYL-4'-(METHYLSULFANYL)BIPHENYL-3-
HETNAM 2 3EQ YL]SULFAMOYL}NAPHTHALEN-1-YL)OXY]ACETIC ACID
HETNAM JZR HEXYL BETA-D-GLUCOPYRANOSIDE
HETNAM IOD IODIDE ION
HETSYN JZR HEXYL BETA-D-GLUCOSIDE; HEXYL D-GLUCOSIDE; HEXYL
HETSYN 2 JZR GLUCOSIDE
FORMUL 3 3EQ 2(C30 H31 N O5 S2)
FORMUL 4 JZR 3(C12 H24 O6)
FORMUL 6 IOD 6(I 1-)
FORMUL 14 HOH *167(H2 O)
HELIX 1 1 ASP A 210 PHE A 226 1 17
HELIX 2 2 THR A 229 THR A 238 1 10
HELIX 3 3 ASP A 251 LYS A 260 1 10
HELIX 4 4 GLU A 276 SER A 302 1 27
HELIX 5 5 ILE A 303 SER A 308 1 6
HELIX 6 6 PHE A 310 ALA A 331 1 22
HELIX 7 7 ARG A 350 SER A 355 1 6
HELIX 8 8 PRO A 359 ALA A 376 1 18
HELIX 9 9 ASP A 380 LEU A 393 1 14
HELIX 10 10 ASN A 402 HIS A 425 1 24
HELIX 11 11 TYR A 430 GLU A 460 1 31
HELIX 12 12 HIS A 466 LYS A 474 1 9
HELIX 13 13 ASP B 210 PHE B 226 1 17
HELIX 14 14 THR B 229 THR B 238 1 10
HELIX 15 15 ASP B 251 LYS B 260 1 10
HELIX 16 16 GLU B 276 SER B 302 1 27
HELIX 17 17 ILE B 303 LEU B 309 1 7
HELIX 18 18 PHE B 310 ALA B 331 1 22
HELIX 19 19 ARG B 350 SER B 355 1 6
HELIX 20 20 PRO B 359 ALA B 376 1 18
HELIX 21 21 ASP B 380 LEU B 393 1 14
HELIX 22 22 ASN B 402 HIS B 425 1 24
HELIX 23 23 TYR B 430 GLU B 460 1 31
HELIX 24 24 HIS B 466 LYS B 474 1 9
SHEET 1 A 4 PHE A 247 ILE A 249 0
SHEET 2 A 4 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249
SHEET 3 A 4 GLY A 338 VAL A 341 -1 N LEU A 339 O VAL A 348
SHEET 4 A 4 VAL A 334 ASN A 335 -1 N ASN A 335 O GLY A 338
SHEET 1 B 4 PHE B 247 ILE B 249 0
SHEET 2 B 4 GLY B 346 THR B 349 1 O PHE B 347 N ILE B 249
SHEET 3 B 4 GLY B 338 VAL B 341 -1 N VAL B 341 O GLY B 346
SHEET 4 B 4 VAL B 334 ASN B 335 -1 N ASN B 335 O GLY B 338
CISPEP 1 LYS A 358 PRO A 359 0 5.14
CISPEP 2 LYS B 358 PRO B 359 0 1.64
CRYST1 39.472 95.535 96.537 90.00 97.76 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.025334 0.000000 0.003453 0.00000
SCALE2 0.000000 0.010467 0.000000 0.00000
SCALE3 0.000000 0.000000 0.010454 0.00000